Advertisement

Supply Chain



While every major hospital association opposes the American Health Care Act, which House republicans unveiled last week, one industry group voiced its support of the legislation, reports The Boston Globe.

Patricia Maryland, DrPH, president of healthcare operations and COO for St. Louis-based Ascension, recently shared her thoughts on the dangers of high drug costs in an opinion piece for the The Hill.

While President Donald Trump initially posed a large threat to biotech companies with talk of price control methods, his power to induce fear is diminishing, Max Nisen, a columnist at Bloomberg Gadfly, wrote Friday in an opinion piece.

Here are six articles published by Becker's Hospital Review this past week featuring insight on why supply chain managers often make great CEOs and the drug industry's claim that high drug prices fund innovation, among other topics.

The Food and Drug Administration is asking for public input on how the agency should define the word "healthy," reports STAT.

Advertisement

Most Read

Advertisement
Advertisement